News

(Upcoming Webinar) Ask the Experts: Gynecologic Clear Cell Carcinoma

February 27, 2026

Watch a replay of this webinar to learn about gynecologic clear cell carcinoma research, treatment, and survivorship. Ovarian Cancer Research Alliance (OCRA) presented an Ask the Experts webinar focused on gynecologic clear cell carcinoma, a rare subtype of gynecologic cancer, on March 25, 2026. This live, interactive webinar featured gynecologic oncologist Aaron Praiss, MD, who discussed current research, treatment … Continued

Community

Global Ovarian Cancer Research Consortium Awards Inaugural AI Accelerator Grant with Microsoft’s AI for Good Lab

February 18, 2026

$1 million global research award, plus an additional $1 million in compute support, advances AI-driven efforts to personalize ovarian cancer care The Global Ovarian Cancer Research Consortium today awarded its inaugural AI Accelerator Grant to an international team of researchers to examine whether artificial intelligence (AI) can improve how survival and treatment response are predicted … Continued

OCRA News

FDA Approves First Ovarian Cancer Immunotherapy for PD-L1–Positive Platinum-Resistant Disease

February 15, 2026

The U.S. Food and Drug Administration (FDA) has approved the first immunotherapy regimen shown to extend survival in a subset of ovarian cancer patients.  The FDA authorized Keytruda (pembrolizumab), made by Merck, in combination with chemotherapy, for PD-L1–positive, platinum-resistant epithelial ovarian, fallopian tube, and primary peritoneal cancers. Keytruda plus weekly Taxol (paclitaxel), with or without … Continued

Research

The Overview: January 2026

February 5, 2026

Ovarian Cancer Research Alliance (OCRA) has announced a collaboration with OPERATION WIPE OUT, an initiative that has demonstrated meaningful success reducing cervical cancer risk in Alabama through prevention-focused education and access to care. Drawing on this proven public-health framework, OCRA will adapt and expand the model nationwide—bringing practical, evidence-based cervical cancer prevention strategies to communities … Continued

OCRA News

New Support Sessions for the Gynecologic Cancer Community

February 5, 2026

Ovarian Cancer Research Alliance (OCRA) has expanded its free, online support offerings with several new weekly sessions for individuals diagnosed with gynecologic cancers, as well as caregivers and family members. These include cervical, vaginal, and vulvar cancer support, caregiver grief support, Spanish-language sessions, and creative wellness programs. OCRA’s support sessions are facilitated by oncology social work professionals. … Continued

Community

OCRA Announces Collaboration with OPERATION WIPE OUT

February 5, 2026

NEW YORK, NY — [February 5, 2026] — Ovarian Cancer Research Alliance (OCRA) has announced a collaboration with OPERATION WIPE OUT, an initiative that has demonstrated meaningful success reducing cervical cancer risk in Alabama through prevention-focused education and access to care. Drawing on this proven public-health framework, OCRA will adapt and expand the model nationwide—bringing practical, evidence-based … Continued

OCRA News

OCRA’s Advocate’s Corner: January 2026

February 5, 2026

Written by Chad Ramsey, OCRA’s Vice President, Policy OCRA’s Advocate Leader Program Reaches Record Size in 2026 January marked a major milestone for Ovarian Cancer Research Alliance’s (OCRA) advocacy community. OCRA trained 94 new advocates to join our Advocate Leaders program, bringing our total to 227 advocates across 44 states and Washington, DC. This is … Continued

Advocacy

OCRA-Funded Study Provides Clear New Evidence That Opportunistic Salpingectomy Drastically Reduces Risk of Ovarian Cancer

February 2, 2026

A new study published February 2 in JAMA Network Open provides the clearest evidence to date that opportunistic salpingectomy—the removal of the fallopian tubes during another gynecologic surgery—can dramatically reduce the risk of ovarian cancer. Led by a B.C.-based international collaboration known as the Ovarian Cancer Observatory, the study found that people who underwent opportunistic … Continued

OCRA News

(Webinar) – Ask the Experts: Gynecologic Sarcoma

January 30, 2026

Watch Now: Ask the Experts Webinar on Gynecologic Sarcoma On January 28, 2026, Ovarian Cancer Research Alliance (OCRA) hosted a live Ask the Experts: Gynecologic Sarcoma webinar with Matthew Hemming, MD, PhD. Moderated by Liza Lundgren, LCSW, OCRA’s Director of Education, this free session featured a live discussion and audience Q&A focused on gynecologic sarcoma research, … Continued

OCRA News

Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection

January 21, 2026

This action alert is now closed. View an update on the FY2026 funding package. The Congressional Appropriations Committees have released a combined FY2026  Defense/Labor, Health and Human Services bill—and it includes several critical investments and policy provisions that would significantly strengthen the federal response to ovarian and other gynecologic cancers. This bill represents meaningful progress … Continued

Advocacy

OCRA Urges Immediate Passage of Bill Supporting Ovarian Cancer Research, Education, and Early Detection

January 20, 2026

The Ovarian Cancer Research Alliance today praised the release of the FY2026 Labor, Health and Human Services, Education, and Related Agencies appropriations bill by the Congressional Appropriations Committees and urged swift action to advance and enact the legislation. The bill includes critical funding and policy provisions supporting ovarian cancer research, education, and early detection. Add Your Voice … Continued

Advocacy

Ovarian Cancer Research Alliance Reports Year of Significant Progress Across Research, Advocacy, and Patient Support

January 13, 2026

Organization launches global initiatives, expands patient programs, strengthens policy leadership, and achieves record engagement in 2025 OCRA is grateful for our community’s generous support, which helped raise over $2.4 million, surpassing our year-end campaign goal and closing out a year of progress.  NEW YORK, NY — [January 13, 2026] — In 2025, Ovarian Cancer Research Alliance (OCRA) delivered … Continued

OCRA News